查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1456997

全球移植市場 - 2024 年至 2029 年預測

Global Transplant Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

移植市場預計將以9.35%的複合年成長率成長，市場規模從2022年的167.09億美元增至2029年的312.38億美元。

移植是指將組織標本或完整器官從原來的位置移植或轉移到另一個位置的過程。與原來的位置相比，移植的器官和組織在一個新的、更健康的環境中得到滋養和生長。移植過程是目前醫療領域廣泛採用的過程。移植過程廣泛用於腎臟、心臟和肝臟等組織和器官。醫療領域發展出來的移植技術為醫療領域帶來了新的發展和創新。慢性病患者數量的增加和手術數量的增加正在推動全球移植市場的成長。人們的健康意識和認知的提高也推動了全球移植市場的成長。政府對促進器官庫和器官移植的支持也促進了全球移植市場的成長。國際醫療組織的宣傳計畫也在促進和鼓勵器官和組織捐贈，為全球移植市場的成長做出貢獻。此外，由於器官登記率的提高，預計未來幾年對器官移植的需求將會增加。器官移植領域進行的研發過程正在為器官移植市場帶來先進的發展與創新。艾伯維公司（Abbvie Inc.）和Arthrex Inc.等大公司對器官移植的投資正在推動全球移植市場的成長。

市場促進因素：

  • 器官移植需求增加，慢性疾病患者增加

器官移植的需求和普及不斷成長正在推動全球器官和組織移植市場的成長。移植方法和手術提供的效率以及移植方法的成功率為全球移植市場的成長提供了潛力。根據PAHO（泛美衛生組織）的報告，美國每年大約進行100例或更多的肺移植手術。美國衛生與公眾服務部表示，截至 2021 年，全國移植等待名單上約有 107,000 人。器官移植和器官登記率的不斷上升正在推動全球移植市場的市場規模不斷擴大。慢性病盛行率上升也是推動全球移植市場成長的關鍵因素之一。根據美國肺臟協會（ALA）的資料，2018年約有900萬成年人患有慢性支氣管炎，導致肺移植或手術。 ALA 也估計，美國每年報告約 20 萬例新肺癌病例。作為某些慢性疾病的有效治療方法，器官和組織移植的需求不斷成長，正在推動全球移植市場的成長。

  • 政府措施和支持

政府和其他組織提供的高水準支持是推動全球移植市場成長的關鍵因素之一。政府措施和政策正在推動全球移植市場的成長。透過政府和私人公司合作開發的器官和組織庫也正在推動全球移植市場的成長。企業對器官移植市場的大量投資正在推動全球移植領域的市場開拓和創新。此外，領先公司推出的新 3D 技術和先進功能的開發正在推動全球移植市場的成長。公共宣傳活動、教育計劃和立法行動等政府措施可以提高器官捐贈的意識並增加捐贈器官的可用性。它還建立和執行器官移植的法律規範，分配研究和開發資金，並加強包括移植中心在內的衛生基礎設施，以確保安全有效的移植程序。

北美地區預計將主導市場

按地區分類，北美地區預計將在全球移植市場中顯著成長。發達的基礎設施和大公司的存在正在促進北美地區的市場成長。慢性病的存在和發生率的增加也推動了全球移植市場的成長。由於其先進的醫療基礎設施、研究和創新、慢性病的高發病率、成熟的器官採購和移植網路、法規環境以及供體器官的可用性，北美預計將主導全球移植市場。 。該地區先進的醫療設施為器官移植手術的成功提供了支持。末期腎功能衰竭、肝功能衰竭和心臟衰竭等慢性疾病的高盛行率正在推動移植手術的需求。法規環境，包括器官共享聯合網路等組織的監督，正在影響移植市場。意識提升的努力有助於增加捐贈器官的可用性。

主要進展

  • 2022 年 10 月 - 蔡司醫療技術公司的新一代電外科雙極鉗 MTLawton 獲得 FDA 批准。這些鑷子由特殊的銅基合金製成，可減少組織粘連和凝固，從而實現高效的準備。延長軸也減少了手術視野中的視覺限制，使外科醫生在電外科手術期間更有效地進行操作。
  • 2022 年 3 月 - Biocomposites 與全球醫療技術領導者 Zimmer Biomet 合作，在美國整形外科市場銷售 Genex 骨移植替代品。這種雙相複合材料旨在平衡骨傳導支架的強度及其在體內的持久性，從而實現最佳的骨架構重建。這份新合約包括針對美國市場的新型封閉式混合系統，減少了準備時間並增加了生產時間。 Genex 還提供更全面的輸送選項，讓外科醫生可以根據他們喜歡的程序注射、成型和準備珠子。

目錄

第1章 簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現
  • 分析師觀點

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章 全球移植市場：依類型

  • 介紹
  • 組織移植
  • 器官移植

第6章 全球移植市場：依最終用途分類

  • 介紹
  • 醫院
  • 移植中心
  • 其他

第7章全球移植市場：按地區

  • 介紹
  • 北美洲
  • 南美洲
  • 歐洲
  • 中東/非洲
  • 亞太地區

第8章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第9章 公司簡介

  • Abbvie Inc.
  • Arthrex Inc.
  • Medtronic PLC
  • Teva Pharmaceuticals
  • Zimmer Biomet
  • Strykers
  • Novartis AG
  • Veloxis Pharmaceuticals
  • 21st Century Medicin
  • BiolifeSolutions Inc
簡介目錄
Product Code: KSI061612245

The transplant market is expected to grow at a CAGR of 9.35%, reaching a market size of US$31.238 billion in 2029 from US$16.709 billion in 2022.

Transplantation is the process of a tissue specimen or a complete organ being transplanted or transferred to another place from its original site. The transplanted organ or tissue will have nourishment and develop in the new, healthier environment compared to the original site. The transplant process is a process that is widely employed in the current medical and healthcare field. The transplantation process is widely used in the case of tissues and organs such as kidneys, hearts, livers, and so on. The transplantation techniques developed in the medical field have given way to new developments and innovations in the medical field. The increasing number of cases of chronic diseases and the rising number of surgeries are driving the market growth of the global transplant market. The rising health awareness and consciousness of people are also driving the market growth of the global transplant market. The support of the government in promoting organ banks and organ transplantation is also contributing to the market growth of the global transplant market. International healthcare organizations' awareness programs are also promoting and encouraging people to donate organs and tissues, which contributes to the global transplant market's growth. The rising rate of organ registration is also expected to increase the demand for organ transplants in the upcoming years. The research and development process taking place in the organ transplant field is resulting in advanced developments and innovations in the organ transplant market. The investment of major players like Abbvie Inc. and Arthrex Inc. in organ transplantation is fuelling the growth of the global transplant market.

MARKET DRIVERS:

  • Rising Demand for Organ Transplants and Increasing Cases of Chronic Diseases

The increasing demand and popularity of organ transplantation are boosting the market growth of the global organ and tissue transplant market. The efficiency offered by transplantation methods or surgeries and the success rate of transplant methods are giving potential to the growth of the global transplant market. According to the reports of PAHO (Pan American Health Organisation), about 100+ lung transplantation surgeries take place in the United States every year. The United States Department of Health and Human Services states that about 107,000 people are on the national transplant waiting list as of 2021. The increased rate of organ transplantation and organ registration is raising the market size of the global transplant market. The rising incidence of chronic diseases is also one of the major factors driving the growth of the global transplant market. According to the data from the ALA (American Lung Association), about 9 million adults suffered from chronic bronchitis in 2018, which led to lung transplantation and surgery. ALA also states that around 200,000 new lung cancers are reported in the U.S. every year. The rising demand for organ and tissue transplantation as an effective treatment for some chronic diseases is driving the market growth of the global transplant market.

  • Government Initiatives and Support

The high level of support offered by governments and other organizations is one of the major factors driving the market growth of the global transplant market. Government initiatives and policies are assisting in the growth of the global transplant market. The organ and tissue banks developed by the collaboration of governments and private companies are also fuelling the growth of the global transplant market. The high investment of companies in the organ transplant market is enhancing the development and innovations in the global transplant field. The development of new 3D technologies and advanced features in the field introduced by major companies is also fuelling the growth of the global transplant market. Government initiatives, including public campaigns, education programs, and legislative measures, can increase organ donation awareness and increase donor organ availability. They also establish and enforce regulatory frameworks for organ transplantation, allocate funding for research and development, and enhance healthcare infrastructure, including transplant centers, to ensure safe and effective transplant procedures.

The region of North America is anticipated to dominate the market

Geographically, the North American region is expected to showcase drastic growth in the global transplant market. The well-developed infrastructure and the presence of leading companies are contributing to the market growth in the North American region. The presence and increasing rate of chronic diseases are also propelling the growth of the global transplant market. North America is expected to dominate the global transplant market due to its advanced healthcare infrastructure, research and innovation, high incidence of chronic diseases, well-established organ procurement and transplantation networks, regulatory environment, availability of donor organs, economic factors, and collaborations between transplant centers, healthcare institutions, and pharmaceutical companies. The region's advanced medical facilities support successful implementation of organ transplantation procedures. The high incidence of chronic diseases, such as end-stage renal disease, liver failure, and heart failure, drives the demand for transplant procedures. The regulatory environment, including oversight by organizations like the United Network for Organ Sharing, influences the transplantation market. The region's efforts in promoting organ donation and transplantation awareness contribute to the higher availability of donor organs.

Key Developments:

  • October 2022- ZEISS Medical Technology has received FDA clearance for its new MTLawton, a new generation of bipolar forceps for electrosurgery. These forceps, made from a special copper-base alloy, reduce tissue adhesion and coagulation for efficient preparation. The extended shaft also reduces visual restrictions in the surgical field, allowing surgeons to perform more efficiently during electrosurgical procedures. The forceps are expected to reduce tissue adhesion and charring during tissue dissection.
  • March 2022- Biocomposites has partnered with global medical technology leader Zimmer Biomet to distribute Genex Bone Graft Substitute in the U.S. orthopedic market. The biphasic composite is designed to balance osteoconductive scaffold strength and persistence in the body, enabling optimal bone architecture remodeling. The new agreement includes a new closed-mixing system for the U.S. market, reducing preparation time and extending working time. Genex also offers a more comprehensive set of delivery options, allowing surgeons to inject, mold, or prepare beads according to their preferred technique.

Market Segmentation

By Type

  • Tissue Transplant
  • Organ Transplant

By End-Use

  • Hospitals
  • Transplant Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL TRANSPLANT MARKET, BY TYPE

  • 5.1. Introduction
  • 5.2. Tissue Transplant
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Organ Transplant
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness

6. GLOBAL TRANSPLANT MARKET, BY END-USE

  • 6.1. Introduction
  • 6.2. Hospitals
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Transplant Centers
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Others
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness

7. GLOBAL TRANSPLANT MARKET, BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. By Type
    • 7.2.2. By End-Use
    • 7.2.3. By Country
      • 7.2.3.1. USA
        • 7.2.3.1.1. Market Opportunities and Trends
        • 7.2.3.1.2. Growth Prospects
      • 7.2.3.2. Canada
        • 7.2.3.2.1. Market Opportunities and Trends
        • 7.2.3.2.2. Growth Prospects
      • 7.2.3.3. Mexico
        • 7.2.3.3.1. Market Opportunities and Trends
        • 7.2.3.3.2. Growth Prospects
  • 7.3. South America
    • 7.3.1. By Type
    • 7.3.2. By End-Use
    • 7.3.3. By Country
      • 7.3.3.1. Brazil
        • 7.3.3.1.1. Market Opportunities and Trends
        • 7.3.3.1.2. Growth Prospects
      • 7.3.3.2. Argentina
        • 7.3.3.2.1. Market Opportunities and Trends
        • 7.3.3.2.2. Growth Prospects
      • 7.3.3.3. Others
        • 7.3.3.3.1. Market Opportunities and Trends
        • 7.3.3.3.2. Growth Prospects
  • 7.4. Europe
    • 7.4.1. By Type
    • 7.4.2. By End-Use
    • 7.4.3. By Country
      • 7.4.3.1. Germany
        • 7.4.3.1.1. Market Opportunities and Trends
        • 7.4.3.1.2. Growth Prospects
      • 7.4.3.2. France
        • 7.4.3.2.1. Market Opportunities and Trends
        • 7.4.3.2.2. Growth Prospects
      • 7.4.3.3. UK
        • 7.4.3.3.1. Market Opportunities and Trends
        • 7.4.3.3.2. Growth Prospects
      • 7.4.3.4. Others
        • 7.4.3.4.1. Market Opportunities and Trends
        • 7.4.3.4.2. Growth Prospects
  • 7.5. Middle East and Africa
    • 7.5.1. By Type
    • 7.5.2. By End-Use
    • 7.5.3. By Country
      • 7.5.3.1. Saudi Arabia
        • 7.5.3.1.1. Market Opportunities and Trends
        • 7.5.3.1.2. Growth Prospects
      • 7.5.3.2. UAE
        • 7.5.3.2.1. Market Opportunities and Trends
        • 7.5.3.2.2. Growth Prospects
      • 7.5.3.3. Others
        • 7.5.3.3.1. Market Opportunities and Trends
        • 7.5.3.3.2. Growth Prospects
  • 7.6. Asia Pacific
    • 7.6.1. By Type
    • 7.6.2. By End-Use
    • 7.6.3. By Country
      • 7.6.3.1. China
        • 7.6.3.1.1. Market Opportunities and Trends
        • 7.6.3.1.2. Growth Prospects
      • 7.6.3.2. India
        • 7.6.3.2.1. Market Opportunities and Trends
        • 7.6.3.2.2. Growth Prospects
      • 7.6.3.3. Japan
        • 7.6.3.3.1. Market Opportunities and Trends
        • 7.6.3.3.2. Growth Prospects
      • 7.6.3.4. South Korea
        • 7.6.3.4.1. Market Opportunities and Trends
        • 7.6.3.4.2. Growth Prospects
      • 7.6.3.5. Taiwan
        • 7.6.3.5.1. Market Opportunities and Trends
        • 7.6.3.5.2. Growth Prospects
      • 7.6.3.6. Thailand
        • 7.6.3.6.1. Market Opportunities and Trends
        • 7.6.3.6.2. Growth Prospects
      • 7.6.3.7. Indonesia
        • 7.6.3.7.1. Market Opportunities and Trends
        • 7.6.3.7.2. Growth Prospects
      • 7.6.3.8. Others
        • 7.6.3.8.1. Market Opportunities and Trends
        • 7.6.3.8.2. Growth Prospects

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Abbvie Inc.
  • 9.2. Arthrex Inc.
  • 9.3. Medtronic PLC
  • 9.4. Teva Pharmaceuticals
  • 9.5. Zimmer Biomet
  • 9.6. Strykers
  • 9.7. Novartis AG
  • 9.8. Veloxis Pharmaceuticals
  • 9.9. 21st Century Medicin
  • 9.10. BiolifeSolutions Inc